Barclays PLC Purchases 575,069 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN)
Barclays PLC grew its position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 444.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 704,371 shares of the company’s stock after purchasing an additional 575,069 shares during the quarter. Barclays PLC owned approximately 0.83% […]
